Validation and development of MTH1 inhibitors for treatment of cancer

U Warpman Berglund, K Sanjiv, H Gad, C Kalderén, T Koolmeister, T Pham, C Gokturk, R Jafari, G Maddalo, B Seashore-Ludlow, A Chernobrovkin, A Manoilov, I S Pateras, A Rasti, A-S Jemth, I Almlöf, O Loseva, T Visnes, B O Einarsdottir, F Z GaugazA Saleh, B Platzack, O A Wallner, K S A Vallin, M Henriksson, P Wakchaure, S Borhade, P Herr, Y Kallberg, P Baranczewski, E J Homan, E Wiita, V Nagpal, T Meijer, N Schipper, S G Rudd, L Bräutigam, A Lindqvist, A Filppula, T-C Lee, P Artursson, J A Nilsson, V G Gorgoulis, J Lehtiö, R A Zubarev, M Scobie, T Helleday

Research output: Contribution to journalArticlepeer-review

104 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Validation and development of MTH1 inhibitors for treatment of cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science